Recursion Pharmaceuticals, Inc. (RXRX)
4.12
+0.05
(+1.23%)
USD |
NASDAQ |
Oct 02, 16:00
4.12
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Price : 4.12 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 4.18 | 4.27 | 4.01 | 4.12 | 18.84M |
| Oct 01, 2026 | 4.07 | 4.17 | 3.96 | 4.07 | 17.48M |
| Sep 30, 2026 | 4.09 | 4.29 | 3.98 | 4.13 | 32.79M |
| Sep 29, 2026 | 3.73 | 4.04 | 3.722 | 4.03 | 21.56M |
| Sep 28, 2026 | 3.69 | 3.840 | 3.665 | 3.70 | 13.06M |
| Sep 25, 2026 | 3.89 | 3.90 | 3.70 | 3.74 | 10.48M |
| Sep 24, 2026 | 3.65 | 3.90 | 3.61 | 3.89 | 19.34M |
| Sep 23, 2026 | 4.03 | 4.09 | 3.66 | 3.70 | 23.67M |
| Sep 22, 2026 | 4.00 | 4.16 | 3.90 | 4.05 | 40.46M |
| Sep 21, 2026 | 3.92 | 4.015 | 3.83 | 3.97 | 37.73M |
| Sep 18, 2026 | 3.54 | 3.83 | 3.50 | 3.83 | 44.33M |
| Sep 17, 2026 | 3.28 | 3.59 | 3.26 | 3.54 | 28.25M |
| Sep 16, 2026 | 3.26 | 3.31 | 3.16 | 3.19 | 14.81M |
| Sep 15, 2026 | 3.37 | 3.37 | 3.22 | 3.24 | 11.88M |
| Sep 14, 2026 | 3.19 | 3.455 | 3.18 | 3.41 | 17.10M |
| Sep 11, 2026 | 3.21 | 3.25 | 3.15 | 3.20 | 8.034M |
| Sep 10, 2026 | 3.14 | 3.25 | 3.10 | 3.16 | 10.63M |
| Sep 09, 2026 | 3.42 | 3.45 | 3.21 | 3.215 | 14.20M |
| Sep 08, 2026 | 3.58 | 3.59 | 3.43 | 3.44 | 14.99M |
| Sep 04, 2026 | 3.415 | 3.70 | 3.41 | 3.63 | 29.04M |
| Sep 03, 2026 | 3.435 | 3.45 | 3.290 | 3.44 | 13.75M |
| Sep 02, 2026 | 3.34 | 3.489 | 3.285 | 3.38 | 14.05M |
| Sep 01, 2026 | 3.34 | 3.38 | 3.280 | 3.33 | 9.997M |
| Aug 31, 2026 | 3.305 | 3.41 | 3.25 | 3.40 | 13.91M |
| Aug 28, 2026 | 3.40 | 3.45 | 3.31 | 3.34 | 10.56M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Editas Medicine, Inc. | 2.62 |
| Amgen, Inc. | 403.04 |
| Halozyme Therapeutics, Inc. | 109.86 |
| Novavax, Inc. | 10.46 |
| AVITA Medical, Inc. | 12.72 |
Price Related Metrics
| PS Ratio | 38.22 |
| Price to Book Value | 2.405 |
| Earnings Yield | -25.15% |
| Market Cap | 2.201B |